Last reviewed · How we verify
Liuwei Dihuang pills
Liuwei Dihuang pills is a Small molecule drug developed by China Academy of Chinese Medical Sciences. It is currently in Phase 2 development.
At a glance
| Generic name | Liuwei Dihuang pills |
|---|---|
| Sponsor | China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency (PHASE2)
- A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills
- CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome (NA)
- Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Liuwei Dihuang pills CI brief — competitive landscape report
- Liuwei Dihuang pills updates RSS · CI watch RSS
- China Academy of Chinese Medical Sciences portfolio CI
Frequently asked questions about Liuwei Dihuang pills
What is Liuwei Dihuang pills?
Liuwei Dihuang pills is a Small molecule drug developed by China Academy of Chinese Medical Sciences.
Who makes Liuwei Dihuang pills?
Liuwei Dihuang pills is developed by China Academy of Chinese Medical Sciences (see full China Academy of Chinese Medical Sciences pipeline at /company/china-academy-of-chinese-medical-sciences).
What development phase is Liuwei Dihuang pills in?
Liuwei Dihuang pills is in Phase 2.